Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
Injectable Thermosensitive Hydrogels for a Sustained Release of Iron Nanochelators
Deferoxamine (DFO) is an FDA‐approved iron‐chelating agent which shows good therapeutic efficacy, however, its short blood half‐life presents challenges such as the need for repeated injections or continuous infusions. Considering the lifelong need of chelating agents for iron overload patients, a sustained‐release formulation that can reduce the number of chelator administrations is essential. Here, injectable hydrogel formulations prepared by integrating crosslinked hyaluronic acid into Pluronic F127 for an extended release of DFO nanochelators are reported. The subcutaneously injected hydrogel shows a thermosensitive sol–gel transition at physiological body temperature and provides a prolonged release of renal clearable nanochelators over 2 weeks, resulting in a half‐life 47‐fold longer than that of the nanochelator alone. In addition, no chronic toxicity of the nanochelator‐loaded hydrogel is confirmed by biochemical and histological analyses. This injectable hydrogel formulation with DFO nanochelators has the potential to be a promising formulation for the treatment of iron overload disorders.
Injectable Thermosensitive Hydrogels for a Sustained Release of Iron Nanochelators
Deferoxamine (DFO) is an FDA‐approved iron‐chelating agent which shows good therapeutic efficacy, however, its short blood half‐life presents challenges such as the need for repeated injections or continuous infusions. Considering the lifelong need of chelating agents for iron overload patients, a sustained‐release formulation that can reduce the number of chelator administrations is essential. Here, injectable hydrogel formulations prepared by integrating crosslinked hyaluronic acid into Pluronic F127 for an extended release of DFO nanochelators are reported. The subcutaneously injected hydrogel shows a thermosensitive sol–gel transition at physiological body temperature and provides a prolonged release of renal clearable nanochelators over 2 weeks, resulting in a half‐life 47‐fold longer than that of the nanochelator alone. In addition, no chronic toxicity of the nanochelator‐loaded hydrogel is confirmed by biochemical and histological analyses. This injectable hydrogel formulation with DFO nanochelators has the potential to be a promising formulation for the treatment of iron overload disorders.
Injectable Thermosensitive Hydrogels for a Sustained Release of Iron Nanochelators
Park, Seung Hun (Autor:in) / Kim, Richard S. (Autor:in) / Stiles, Wesley R. (Autor:in) / Jo, Minjoo (Autor:in) / Zeng, Lingxue (Autor:in) / Rho, Sunghoon (Autor:in) / Baek, Yoonji (Autor:in) / Kim, Jonghan (Autor:in) / Kim, Moon Suk (Autor:in) / Kang, Homan (Autor:in)
Advanced Science ; 9
01.05.2022
9 pages
Aufsatz (Zeitschrift)
Elektronische Ressource
Englisch
Injectable, thermosensitive, fast gelation, bioeliminable, and oxygen sensitive hydrogels
| British Library Online Contents | 2019
Preparation of Thermosensitive Hybrid Hydrogels for Biomaterials in Drug Release
| British Library Online Contents | 2003
| British Library Online Contents | 2018
Investigation of charge effects on drug release behavior for ionic thermosensitive hydrogels
| British Library Online Contents | 2002
Supramolecular cyclodextrin pseudorotaxane hydrogels: A candidate for sustained release?
| British Library Online Contents | 2014